38869-07-7

Usage

Uses

Used in Pharmaceutical Research:
1-(3,4,5-Trimethoxyphenyl)-piperazine hydrochloride is used as a research tool for studying the effects and mechanisms of serotonin receptor agonists. Its application in this field aids in the understanding of various neurological and psychiatric disorders.
Used in the Treatment of Neurological and Psychiatric Disorders:
In the medical industry, 1-(3,4,5-Trimethoxyphenyl)-piperazine hydrochloride is used as a potential therapeutic agent for treating conditions such as depression, anxiety, and schizophrenia. Its agonistic action on serotonin receptors contributes to the development of novel treatment strategies for these disorders.
Used in Pain Management Research:
1-(3,4,5-Trimethoxyphenyl)-piperazine hydrochloride is also used as an analgesic agent, with investigations into its potential role in modulating pain perception. This application has shown promise in advancing the development of new pain management therapies.
Used in Drug Development:
In the pharmaceutical industry, 1-(3,4,5-Trimethoxyphenyl)-piperazine hydrochloride serves as a key compound in the development of innovative therapeutic agents targeting neurological and psychiatric conditions, as well as pain management. Its selective agonistic properties on serotonin receptors make it a valuable asset in creating effective medications.

Upstream product

• 821-48-7 bis-(2-chloroethyl)amine hydrochloride 
• 24313-88-0 3,4,5-Trimethoxyaniline 
• 43204-63-3 bis(2-bromoethyl)amine hydrobromide 

Downstream Products

• 80305-32-4 N-(3,4,5-trimethoxy-benzyl)-N'-(3,4,5-trimethoxyphenyl)-piperazine hydrochloride 
• 91703-26-3 5-[4-(3,4,5-trimethoxyphenyl)piperazin-1-yl]pyrrolidin-2-one 
• 117518-17-9 N-[2-(dimethylamino)ethyl]-4-(3,4,5-trimethoxyphenyl)-1-piperazinecarboxamide 
• 136270-38-7 5,8-Dimethoxy-2,3-bis-{4-[4-(3,4,5-trimethoxy-phenyl)-piperazin-1-ylmethyl]-phenyl}-quinoxaline 
• 116290-44-9 1-phenoxy-4-[4-(3,4,5-trimethoxyphenyl)-1-piperazinyl]-2-butanol 

Relevant academic research and scientific papers

Series of 5-[-(4-aryl-1-piperazinyl)alkyl]-2-oxazolidinone derivatives useful in the treatment of allergic conditions

A method of treating allergic disorders and pharmaceutical compositions therefore are disclosed for a series of 5-[(4-aryl-1-piperazinyl)alkyl]-2-oxazolidinone derivatives of Formula I. These compounds are useful in inhibiting Type I allergic STR1 responses in a living animal and thus can be used to treat allergic phenomena such as asthma, rhinitis, atopic dermatitis, chronic hives, allergic conjunctivitis and the like.

Therapeutic agent for liver disease and piperazine derivatives

A therapeutic agent for liver disease containing as an active ingredient a piperazine derivative having the formula: STR1 wherein, A represents a phenyl, p-benzoquinonyl or cumarinyl group which may have at least one substituent selected from the group consisting of halogen, alkyl, fluoroalkyl, formyl, alkoxycarbonyl, acyl, hydroxy, alkoxy, acyloxy, glycosyloxy, amino, alkylamino, mercapto, alkylthio and nitro; B represents a single bond or a straight chain alkylene group containing 1-4 carbon atoms which may have at least one substituent selected from the group consisting of alkyl, aryl, aralkyl, hydroxy and oxo; R represents an atom or a group selected from the group consisting of hydrogen, alkali metal, alkaline earth metal, alkyl, cycloalkyl, aralkyl and aryl; and n is 2 or 3, or its pharmaceutically acceptable salt is disclosed.

Pharmaceutically useful carbostyril derivatives

Carbostyril derivatives having antihistamic action and central nervous controlling action are useful as antihistamic agents or central nervous controlling agents. The derivatives are represented by the general formula, STR1 wherein R1 is a hydr